| Date | Title | Description |
| 12.06.2024 | Beghou Consulting expands end-to-end life sciences commercialization capabilities | Beghou Consulting supports the end-to-end life sciences brand lifecycle with a blend of deep domain knowledge, data science and advanced analytics expertise, and powerful technology.
Rohit Gupta, Abhigya Jain and Nilanshu Sinha become new P... |
| 03.06.2024 | Beghou Consulting strengthens omnichannel and customer engagement capabilities with addition of new Partners | Beghou Consulting supports the end-to-end life sciences brand lifecycle with a blend of deep domain knowledge, data science and advanced analytics expertise, and powerful technology.
To help clients drive meaningful and differentiated engag... |
| 23.05.2024 | Spectrum Science CEO Jonathan Wilson Appoints Amy Hutnik as President | Spectrum Science, a full-service strategic platform offering integrated engagement, retention, marketing, communications and advisory services for the health and life science industries, today announced the appointment of Amy Hutnik to the ... |
| 06.03.2024 | Tonix Pharmaceuticals Selects EVERSANA® to Support Launch Strategy and Commercialization Planning of Tonmya™ for the Management of Fibromyalgia | - |
| 14.12.2023 | European Life Science Companies Join Forces With EVERSANA for Global Pharma Solutions | Driven to transform and unify commercialisation services for pharmaceutical brands entering or expanding into Europe, EVERSANA, a leading provider of commercialisation services to the life sciences industry, has united seven leading organiz... |
| 27.11.2023 | EVERSANA Expands Commitment to “Pharmatize” AI with Amazon Web Services | The new generative-AI powered offering comes just months after the organizations came together to determine novel ways to leverage AI to solve complex challenges facing life sciences
Building on a promise to “pharmatize” artificial intellig... |
| 02.06.2023 | EVERSANA Forms Strategic Alliance with China Resource Pharmaceutical Commercial Group to Bring New Novel Treatments to Patients Globally | BEIJING, June 2, 2023 /PRNewswire/ -- EVERSANA®, a leading provider of commercialization services to the global life sciences industry, today announced that it has established a strategic alliance with the China Resources Pharmaceutical Com... |
| 22.03.2023 | APACMed Names EVERSANA Knowledge Partner to Shape Digital Health Reimbursement Framework Across Region | SINGAPORE, March 22, 2023 /PRNewswire/ -- Asia Pacific Medical Technology Association (APACMed), the region's leading organization for medical technology manufacturers, has named EVERSANA®, a pioneer of next-generation commercial services t... |
| 22.03.2023 | APACMed Names EVERSANA Knowledge Partner to Shape Digital Health Reimbursement Framework Across Region | SINGAPORE, March 21, 2023 /PRNewswire/ -- Asia Pacific Medical Technology Association (APACMed), the region's leading organization for medical technology manufacturers, has named EVERSANA®, a pioneer of next-generation commercial services t... |
| 23.02.2023 | Xspray Pharma Partners with EVERSANA® for the U.S. Launch and Commercialization of its Lead Product, Dasynoc (XS004) for the Treatment of Chronic Myeloid Leukemia (CML) and Acute Lymphatic Leukemia (A... | STOCKHOLM, Feb. 23, 2023 /PRNewswire/ -- Xspray Pharma AB, (NASDAQ Stockholm: XSPRAY) has signed an agreement with EVERSANA® to support the U.S. launch and commercialization of the company's first innovative cancer therapy Dasynoc for the t... |
| 22.02.2023 | EVERSANA CONSULTING Named a Top Ranked Consulting Firm by Vault Across Asia Pacific | SINGAPORE and CHICAGO, Feb. 22, 2023 /PRNewswire/ -- EVERSANA®, a pioneer of next-generation commercial services to the global life sciences industry, today announced its strategic consulting arm EVERSANA® CONSULTING, has been named to Vaul... |
| 08.02.2023 | EVERSANA CONSULTING Named a Best Boutique Consulting Firm by Vault For the Second Consecutive Year | CHICAGO, Feb. 8, 2023 /PRNewswire/ -- EVERSANA®, a pioneer of next-generation commercial services to the global life sciences industry, today announced its strategic consulting arm EVERSANA® CONSULTING has been named to Vault's 2023 Best Bo... |
| 13.07.2022 | EVERSANA™ Announces Strategic Partnership with Compai Pharma to Expand Commercialisation Services Across the Asia Pacific Region | CHICAGO and SINGAPORE, July 13, 2022 /PRNewswire/ -- EVERSANA™, a pioneer of next-generation commercial services to the global life sciences industry with its Asian regional headquarters in Singapore and offices across Japan, China and othe... |
| 04.05.2022 | Heart to Heart International and Intouch Group Partner to Place Much-Needed Labs in Safety-Net Clinics | Heart to Heart International Adopt-a-Lab
LENEXA, Kan. (PRWEB) May 04, 2022
Heart to Heart International (HHI), a global humanitarian organization focused on improving access to health, today announced a partnership with Intouch Group, an EV... |
| 17.03.2022 | EVERSANA unveils global price and market access solution NAVLIN by EVERSANA | Next generation price and market access platform combining data, software and insights into single ecosystem
CHICAGO, March 17, 2022 /PRNewswire/ -- EVERSANA™, the pioneer of next generation commercial services to the global life sciences i... |
| 21.12.2021 | EVERSANA Completes Acquisition of Intouch Group, Adds the Premiere Digital-First Agency Network to the Market Leader in Next Generation Commercialization | EVERSANA, the pioneer of next generation commercial services to the global life sciences industry, announced it has completed its acquisition of Intouch Group, a full-service global agency network serving the pharmaceutical industry. The ac... |
| 08.11.2021 | Q BioMed Bolsters Commercialization of Strontium89 with EVERSANA Partnership | NEW YORK and CHICAGO, Nov. 8, 2021 /PRNewswire/ -- Q BioMed Inc. (OTCQB: QBIO) a biotech acceleration and commercial stage company focused on licensing and acquiring undervalued biomedical assets in the healthcare sector, today announced it... |
| 08.11.2021 | Q BioMed Bolsters Commercialization of Strontium89 with EVERSANA Partnership | NEW YORK and CHICAGO, Nov. 8, 2021 /PRNewswire/ -- Q BioMed Inc. (OTCQB: QBIO) a biotech acceleration and commercial stage company focused on licensing and acquiring undervalued biomedical assets in the healthcare sector, today announced it... |
| 11.10.2021 | EVERSANA™ named a Great Place to Work for third consecutive year in U.S.; earns valuable recognition in Canada, China and India | CHICAGO, Oct. 11, 2021 /PRNewswire/ -- EVERSANA™, the pioneer of next generation commercial services to the global life sciences industry, is celebrating its designation as a Great Place to Work® by the global authority in workplace culture... |
| 22.09.2021 | Proposals to cap Medicare Part B payments will limit outpatient access to CAR-T | The revolutionary life-extending approach to treating cancer known as CAR-T is under threat from a quotidian source: policy proposals to limit Medicare reimbursement in the outpatient setting to the average sales price of the treatment plus... |
| 17.08.2021 | Shorla Pharma Announces Partnership with EVERSANA to Support the Launch and Commercialization of T-cell Leukemia Treatment | |
| 26.07.2021 | EVERSANA™ expands global commercialization solutions with acquisition of Accelera Canada and its partner companies | |
| 22.06.2021 | EVERSANA Expands Medical Information and Integrated Compliance Services Across Europe | EVERSANA, the pioneer of next generation commercial services to the global life sciences industry, announced a broad expansion of its integrated compliance services across Europe, including leading medical information (MI) operations across... |
| 21.06.2021 | EVERSANA :™ expands medical information and integrated compliance services across Europe | CHICAGO, June 21, 2021 /PRNewswire/ -- EVERSANA™, the pioneer of next generation commercial services to the global life sciences industry, today announced a broad expansion of its integrated compliance services across Europe, including lead... |
| 14.06.2021 | GENinCode announces major US commercialisation partnership with EVERSANA | |
| 06.05.2021 | EVERSANA advances commercialization readiness as Humanigen announces publication of phase 3 randomized double-blind placebo-controlled study demonstrating the efficacy and safety of lenzilumab™ in new... | |
| 23.03.2021 | Eyenovia and EVERSANA Announce Partnership to Support the Potential Launch and Commercialization of MydCombi™ for Mydriasis | NEW YORK & CHICAGO--(BUSINESS WIRE)--Mar 23, 2021--
Eyenovia, Inc. (NASDAQ: EYEN), a clinical stage ophthalmic company developing a pipeline of advanced therapeutics based on its proprietary Microdose Array Print (MAP™) platform technol... |
| 25.02.2021 | EVERSANA Launches Chronic Disease Real-World Data Solution Covering More Than 80 Million Deidentified Patients to Drive Regulatory-Grade Clinical Research and Improve Patient Outcomes | |
| 09.11.2020 | EVERSANA announces broad-scale strategic partnerships with industry leaders in claims, EMR, formulary and provider-institutional data to optimize real-time commercial services | |
| 16.09.2020 | EVERSANA launches ACTICS by EVERSANA™, the technology-enabled solution combining predictive analytics integrated with real-time commercial services to drive next best action in the life science sector... | |
| 09.09.2020 | EVERSANA™ expands pharmaceutical training and digital engagement capabilities with acquisition of Alkemy Partners | |
| 14.07.2020 | Sharpening The Value And Definitions Of Digital And RWD: An Exchange Between Two Industry Leaders | President of Data & Analytics, at Eversana. |
| - | Shorla Announces Partnership with EVERSANA to Support the Launch and Commercialization of T-cell Leukemia Treatment. | Cambridge, Massachusetts, USA. 17 August, 2021. Seroba’s portfolio company, Shorla Pharma (‘Shorla’), a specialty pharmaceutical company and EVERSANA™, the pioneer of next generation commercial services to the global life sciences industry,... |
